C P Vendrik - JoVE Visualize

Showing results (11-20 of 17) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 17 results.

Cancer|May 1, 1984

Cyvadic in advanced soft tissue sarcoma: a randomized study comparing two schedules. A study of the EORTC Soft Tissue and Bone Sarcoma GroupH M Pinedo, V H Bramwell, H T Mouridsen, et al.

Cancer Research|May 15, 1987

Multivariate analysis of prognostic factors in patients with disseminated nonseminomatous testicular cancer: results from a European Organization for Research on Treatment of Cancer Multiinstitutional Phase III StudyG Stoter, R Sylvester, D T Sleijfer, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1989

Ten-year survival and late sequelae in testicular cancer patients treated with cisplatin, vinblastine, and bleomycinG Stoter, A Koopman, C P Vendrik, et al.

European Journal of Cancer (Oxford, England : 1990)|January 1, 1991

Long-term follow-up of non-seminomatous testicular cancer patients with mature teratoma or carcinoma at postchemotherapy surgery. EORTC Genitourinary Tract Cancer Cooperative Group (EORTC GU Group)R L Jansen, R Sylvester, D T Sleyfer, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1986

High-dose versus low-dose vinblastine in cisplatin-vinblastine-bleomycin combination chemotherapy of non-seminomatous testicular cancer: a randomized study of the EORTC Genitourinary Tract Cancer Cooperative GroupG Stoter, D T Sleyfer, W W ten Bokkel Huinink, et al.

Cancer Chemotherapy and Pharmacology|January 1, 1997

Response of sensitive and resistant IgM immunocytomas to cis-diamminedichloroplatinum (II) does not correlate with the platination level or with the formation or removal of DNA adductsC P Vendrik, A M Fichtinger-Schepman, W C van Dijk-Knijnenburg, et al.

Cancer Research|June 1, 1989

Platinum concentrations and DNA adduct levels in tumors and organs of cisplatin-treated LOU/M rats inoculated with cisplatin-sensitive or -resistant immunoglobulin M immunocytomaA M Fichtinger-Schepman, C P Vendrik, W C van Dijk-Knijnenburg, et al.

Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 17 results.

Cancer|May 1, 1984

Cyvadic in advanced soft tissue sarcoma: a randomized study comparing two schedules. A study of the EORTC Soft Tissue and Bone Sarcoma GroupH M Pinedo, V H Bramwell, H T Mouridsen, et al.

Cancer Research|May 15, 1987

Multivariate analysis of prognostic factors in patients with disseminated nonseminomatous testicular cancer: results from a European Organization for Research on Treatment of Cancer Multiinstitutional Phase III StudyG Stoter, R Sylvester, D T Sleijfer, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1989

Ten-year survival and late sequelae in testicular cancer patients treated with cisplatin, vinblastine, and bleomycinG Stoter, A Koopman, C P Vendrik, et al.

European Journal of Cancer (Oxford, England : 1990)|January 1, 1991

Long-term follow-up of non-seminomatous testicular cancer patients with mature teratoma or carcinoma at postchemotherapy surgery. EORTC Genitourinary Tract Cancer Cooperative Group (EORTC GU Group)R L Jansen, R Sylvester, D T Sleyfer, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1986

High-dose versus low-dose vinblastine in cisplatin-vinblastine-bleomycin combination chemotherapy of non-seminomatous testicular cancer: a randomized study of the EORTC Genitourinary Tract Cancer Cooperative GroupG Stoter, D T Sleyfer, W W ten Bokkel Huinink, et al.

Cancer Chemotherapy and Pharmacology|January 1, 1997

Response of sensitive and resistant IgM immunocytomas to cis-diamminedichloroplatinum (II) does not correlate with the platination level or with the formation or removal of DNA adductsC P Vendrik, A M Fichtinger-Schepman, W C van Dijk-Knijnenburg, et al.

Cancer Research|June 1, 1989

Platinum concentrations and DNA adduct levels in tumors and organs of cisplatin-treated LOU/M rats inoculated with cisplatin-sensitive or -resistant immunoglobulin M immunocytomaA M Fichtinger-Schepman, C P Vendrik, W C van Dijk-Knijnenburg, et al.

Pageof 2